Prostate cancer prognosis linked to prostate-specific antigen levels below threshold

After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that treatment is working. A recent real-world study indicates that reaching a PSA level below 0.2 ng/mL is an indicator of improved patient survival. The study is published online in CANCER.

source https://medicalxpress.com/news/2026-08-prostate-cancer-prognosis-linked-specific.html